Gene | Residue No. | Non Virulenta | Virulenta | A/ck/Eg/BSU-CU/11 | Egypt H9N2 2006b | Middle East H9N2c |
---|
PA | 672 | F | L | L | L | L |
NP | 398 | K | Q | Q | Q | Q |
M1 | 195 | A | S | S | S | S |
M2 | 14 | E | G | E | G | E30A3G59 |
NS1 | 25 | R | Q | Q | Q | Q |
 | 225 | A | T | T | T | A1LR1rT69 |
NS2 | 14 | T | M/I/K | M | M | K4M31L5V2Q2 |
- aVirulent and non virulent amino acid residues refer to the ability of the virus to replicate in mice as determined by Li et al. [51].
- bA/avian/Egypt/920431/2006(H9N2)) is GenBank available data. The strain isolated from live bird market in Egypt (unpublished report).
- cAll available H9N2 sequences from the Middle East. The available H9N2 sequences include strains from Emirates, Iran, Israel, Jordan, Lebanon, Saudi Arabia and Tunisia found in the Flu database.
- Numerical superscripts refer to the number of strains that possess those residues.